Steven Page Trio Headlines NYC Benefit Concert for APFED on 11/7

October 24, 2019

“Charit-EoE Concert for a Cure for Eosino…what???” will help fund research for eosinophil-associated diseases

(Atlanta, GA)— The Steven Page Trio is set to perform at a special benefit concert on Thursday, November 7 at TGA NYC in New York City, with doors opening at 7:00 p.m.  Steven Page is a founding member of the popular rock sensation Barenaked Ladies and a 2018 Inductee to the Canadian Rock & Roll Hall of Fame.

Arlene and Lance Steinberg are chairing this evening of music and fundraising to benefit APFED’s HOPE on the Horizon Research Program. The Steinbergs have a son who has been diagnosed with eosinophilic esophagitis (EoE), a chronic allergic condition of the esophagus that is believed to be triggered by allergies to food. The condition can range from mild to severe symptoms, and left untreated, can cause the esophagus to stiffen and narrow, causing difficulty swallowing.

Tickets to the benefit concert may be purchased here for a cost of $150 per person. The ticket price includes three hours of cocktails, light fare, a gift bag filled with a variety of items from generous sponsors, and an unforgettable evening of music, community, awareness, and fun.

Proceeds from the concert will benefit APFED’s HOPE on the Horizon Research Program, which awards grants to investigators who initiate new projects relevant to eosinophilic esophagitis (EoE) and other eosinophil-associated diseases.

“I met with the Steinberg family in 2016. Before then, I knew nothing about eosinophil-associated diseases,” shared Steven Page.  “I learned very quickly how devastating they can be. I also learned how tightly knit the community of families who are living with these disorders are, and I am honored to be able to support them with music.”

“We saw a need to bring back our event for a third year, and we are delighted that Steven Page and his trio will be headlining,” said Arlene Steinberg. “We’re thankful to the Steven Page Trio for sharing an amazing night of music with this community and for the community’s continued support of APFED and its groundbreaking research program.”

“Over the years, we’ve truly valued this unique concert experience that the Steinbergs have hosted to benefit APFED’s research program. Our entire community is grateful for how their efforts have advanced our understanding of these rare diseases,“ added APFED Executive Director Mary Jo Strobel. “This event truly creates hope through the new projects that it makes possible.”

APFED appreciates the support of the following Double Platinum sponsors: Brandt, Steinberg, Lewis & Blond LLP; Sunshine Charitable Foundation; Tito’s Handmade Vodka; and TGA NYC.

About American Partnership for Eosinophilic Disorders (APFED)

American Partnership for Eosinophilic Disorders (APFED) is a non-profit organization dedicated to patients and their families coping with eosinophilic disorders. APFED’s mission is to passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy.

 About Eosinophilic Esophagitis (EoE)

Eosinophilic esophagitis (EoE) is a chronic, allergic inflammatory disease of the esophagus (the tube connecting the mouth to the stomach). It occurs when a type of white blood cell, the eosinophil, accumulates in the esophagus and persists despite acid-blocking medicine. The elevated number of eosinophils cause injury and inflammation to the esophagus. This damage may make eating difficult or uncomfortable, potentially resulting in poor growth, chronic pain, and/or difficulty swallowing.

EoE is a subset of a group of rare, chronic conditions known as eosinophil-associated diseases. When a person has elevated numbers of eosinophils in their digestive system, tissues, organs, and/or bloodstream, without a known cause, he or she may have an eosinophil-associated disease. Due to the lack of information or awareness of these diseases, patients may suffer for years trying to obtain an accurate diagnosis and appropriate treatment.  Although not commonly life-threatening, these chronic diseases require lifelong treatment and can cause debilitating symptoms. There is no cure and no FDA-approved treatments.



Join us July 11-13 in Washington, DC or online for EOS Connection 2024!